AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
A CHEMOKINE RECEPTOR CCR2 ALLELE DELAYS HIV-1 DISEASE PROGRESSION ANDIS ASSOCIATED WITH A CCR5 PROMOTER MUTATION
Authors: KOSTRIKIS LG HUANG YX MOORE JP WOLINSKY SM ZHANG LQ GUO Y DEUTSCH L PHAIR J NEUMANN AU HO DD
Citation: Lg. Kostrikis et al., A CHEMOKINE RECEPTOR CCR2 ALLELE DELAYS HIV-1 DISEASE PROGRESSION ANDIS ASSOCIATED WITH A CCR5 PROMOTER MUTATION, Nature medicine, 4(3), 1998, pp. 350-353
A RANDOMIZED, CONTROLLED, DOUBLE-BLIND-STUDY COMPARING THE SURVIVAL BENEFIT OF 4 DIFFERENT REVERSE-TRANSCRIPTASE INHIBITOR THERAPIES (3-DRUG, 2-DRUG, AND ALTERNATING DRUG) FOR THE TREATMENT OF ADVANCED AIDS
Authors: HENRY K ERICE A TIERNEY C BALFOUR HH FISCHL MA KMACK A LIOU SH KENTON A HIRSCH MS PHAIR J MARTINEZ A KAHN JO
Citation: K. Henry et al., A RANDOMIZED, CONTROLLED, DOUBLE-BLIND-STUDY COMPARING THE SURVIVAL BENEFIT OF 4 DIFFERENT REVERSE-TRANSCRIPTASE INHIBITOR THERAPIES (3-DRUG, 2-DRUG, AND ALTERNATING DRUG) FOR THE TREATMENT OF ADVANCED AIDS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(4), 1998, pp. 339-349
ANALYSIS OF A BIALLELIC POLYMORPHISM IN THE TUMOR-NECROSIS-FACTOR A PROMOTER AND HIV TYPE-1 DISEASE PROGRESSION
Authors: KNUCHEL MC SPIRA TJ NEUMANN AU XIAO LH RUDOLPH DL PHAIR J WOLINSKY SM KOUP RA COHEN OJ FOLKS TM LAL RB
Citation: Mc. Knuchel et al., ANALYSIS OF A BIALLELIC POLYMORPHISM IN THE TUMOR-NECROSIS-FACTOR A PROMOTER AND HIV TYPE-1 DISEASE PROGRESSION, AIDS research and human retroviruses, 14(4), 1998, pp. 305-309
GENETIC RESTRICTION OF AIDS PATHOGENESIS BY AN SDF-1 CHEMOKINE GENE VARIANT
Authors: WINKLER C MODI W SMITH MW NELSON GW WU XY CARRINGTON M DEAN M HONJO T TASHIRO K YABE D BUCHBINDER S VITTINGHOFF E GOEDERT JJ OBRIEN TR JACOBSON LP DETELS R DONFIELD S WILLOUGHBY A GOMPERTS E VLAHOV D PHAIR J OBRIEN SJ
Citation: C. Winkler et al., GENETIC RESTRICTION OF AIDS PATHOGENESIS BY AN SDF-1 CHEMOKINE GENE VARIANT, Science, 279(5349), 1998, pp. 389-393
PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: MASUR H KAPLAN JE HOLMES KK BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Clinical infectious diseases, 25, 1997, pp. 299
1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/
Authors: MASUR H KAPLAN JE HOLMES KK ARMSTRONG D BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/, Clinical infectious diseases, 25, 1997, pp. 313-335
CYTOMEGALOVIRUS (CMV) CULTURE RESULTS, DRUG-RESISTANCE, AND CLINICAL OUTCOME IN PATIENTS WITH AIDS AND CMV RETINITIS TREATED WITH FOSCARNETOR GANCICLOVIR
Authors: LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO T TUTTLE C JABS DA APUZZO L BARTLETT J COLESON L DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN MH POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG AW JUSTIN N TEICH S SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MACARTHURCHANG L FREEMAN WR MEIXNERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R DODGE JM STEVENS M BROWNBELLAMY J KLEMM AC MARKOWITZ JA WEBB R MEINERT CL AMENDLIBERCCI D COLESONSCHREUR L COLLINS KL COLLISON BJ DODGE J DONITHAN M FINK N KAPLANGILPIN AM GERCZAK C HOLBROOK JT ISAACSON MR LANE MF LEVINE CR MARTIN BK MIN YI OWENS RM NOWAKOWSKI DJ SAAH A TONASCIA J VANNATTA ML DAVIS MD AGRESSEGAL M ARMSTRONG J BROTHERS R FREITAG G HUBBARD L HURLBURT D KASTORFF L MAGLI Y MINER K THOMAS S VANDERHOOFYOUNG M DREW WL MINOR R STEWART G HUGHES R WELCH L MOWERY R ELLENBERG S KORVICK J SATTLER F BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H WHITLEY R
Citation: Ra. Lewis et al., CYTOMEGALOVIRUS (CMV) CULTURE RESULTS, DRUG-RESISTANCE, AND CLINICAL OUTCOME IN PATIENTS WITH AIDS AND CMV RETINITIS TREATED WITH FOSCARNETOR GANCICLOVIR, The Journal of infectious diseases, 176(1), 1997, pp. 50-58
HETEROZYGOSITY FOR A DEFECTIVE GENE FOR CC-CHEMOKINE RECEPTOR-5 IS NOT THE SOLE DETERMINANT FOR THE IMMUNOLOGICAL AND VIROLOGICAL PHENOTYPEOF HIV-INFECTED LONG-TERM NONPROGRESSORS
Authors: COHEN OJ VACCAREZZA N LAM GK BAIRD BF WILDT K MURPHY PM ZIMMERMAN PA NUTMAN TB FOX CH HOOVER S ADELSBERGER J BASELER M ARTHOS J DAVEY RT DEWAR RL METCALF J SCHWARTZENTRUBER DJ ORENSTEIN JM BUCHBINDER S SAAH AJ DETELS R PHAIR J RINALDO C MARGOLICK JB PANTALEO G FAUCI AS
Citation: Oj. Cohen et al., HETEROZYGOSITY FOR A DEFECTIVE GENE FOR CC-CHEMOKINE RECEPTOR-5 IS NOT THE SOLE DETERMINANT FOR THE IMMUNOLOGICAL AND VIROLOGICAL PHENOTYPEOF HIV-INFECTED LONG-TERM NONPROGRESSORS, The Journal of clinical investigation, 100(6), 1997, pp. 1581-1589
FOSCARNET-GANCICLOVIR CYTOMEGALOVIRUS RETINITIS TRIAL .5. CLINICAL-FEATURES OF CYTOMEGALOVIRUS RETINITIS AT DIAGNOSIS
Authors: LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO T TUTTLE C JABS DA APUZZO L BARTLETT J COLESON L DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN MH POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG TW JUSTIN N TEICH S SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MACARTHURCHANG L FREEMAN WR MEIXNERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN L IRVINE A JACOBSON M LARSON A SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R CHEESEMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K KLINE JM KLEMM AC STEVENS M WEBB R BROWNBELLAMY J MARKOWITZ JA MEINERT CL BROOKMEYER R COLLINS KB COLLISON BJ DODGE J DONITHAN M FINK N GERCZAK C GILPIN AMK HOLBROOK JT ISAACSON MR LEVINE CR MARTIN B MIN YI MEINERT JL OWENS RM NOWAKOWSKI DJ SAAH A SINGER S SMITH M STERNBERG AL TONASCIA J VANNATTA ML DAVIS MD AGRESSEGAL M ARMSTRONG J BRICKBAUER J BROTHERS R CHOP M FREITAG G HUBBARD L HURLBURT D JENSEN K KASTORFF L KING B MAGLI Y MESSING S MINER K NEIDER M STOPPENBACH V THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R WELCH L MOWERY R ELLENBERG S KORVICK J CLARK T SATTLER F BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H WHITLEY R
Citation: Ra. Lewis et al., FOSCARNET-GANCICLOVIR CYTOMEGALOVIRUS RETINITIS TRIAL .5. CLINICAL-FEATURES OF CYTOMEGALOVIRUS RETINITIS AT DIAGNOSIS, American journal of ophthalmology, 124(2), 1997, pp. 141-157
KSHV ANTIBODIES AMONG AMERICANS, ITALIANS AND UGANDANS WITH AND WITHOUT KAPOSIS-SARCOMA
Authors: GAO SJ KINGSLEY L LI M ZHENG W PARRAVICINI C ZIEGLER J NEWTON R RINALDO CR SAAH A PHAIR J DETELS R CHANG YA MOORE PS
Citation: Sj. Gao et al., KSHV ANTIBODIES AMONG AMERICANS, ITALIANS AND UGANDANS WITH AND WITHOUT KAPOSIS-SARCOMA, Nature medicine, 2(8), 1996, pp. 925-928
INFLUENCE OF COMBINATIONS OF HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX GENES ON THE COURSE OF HIV-1 INFECTION
Authors: KASLOW RA CARRINGTON M APPLE R PARK L MUNOZ A SAAH AJ GOEDERT JJ WINKLER C OBRIEN SJ RINALDO C DETELS R BLATTNER W PHAIR J ERLICH H MANN DL
Citation: Ra. Kaslow et al., INFLUENCE OF COMBINATIONS OF HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX GENES ON THE COURSE OF HIV-1 INFECTION, Nature medicine, 2(4), 1996, pp. 405-411
THE ROLE OF A MUTANT CCR5 ALLELE IN HIV-1 TRANSMISSION AND DISEASE PROGRESSION
Authors: HUANG YX PAXTON WA WOLINSKY SM NEUMANN AU ZHANG LQ HE T KANG S CERADINI D JIN ZQ YAZDANBAKHSH K KUNSTMAN K ERICKSON D DRAGON E LANDAU NR PHAIR J HO DD KOUP RA
Citation: Yx. Huang et al., THE ROLE OF A MUTANT CCR5 ALLELE IN HIV-1 TRANSMISSION AND DISEASE PROGRESSION, Nature medicine, 2(11), 1996, pp. 1240-1243
PHASE-1 STUDY OF COMBINATION THERAPY WITH L-697,661 AND ZIDOVUDINE
Authors: SCHOOLEY RT CAMPBELL TB KURITZKES DR BLASCHKE T STEIN DS ROSANDICH ME PHAIR J POTTAGE JC MESSARI F COLLIER A KAHN J RAY G CURTIS S BAKHTIARI M KESSLER H COOMBS R COREY L VOLBERDING P CALANDRA G MASSARI F
Citation: Rt. Schooley et al., PHASE-1 STUDY OF COMBINATION THERAPY WITH L-697,661 AND ZIDOVUDINE, Journal of acquired immune deficiency syndromes and human retrovirology, 12(4), 1996, pp. 363-370
REPLACING TIME SINCE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION BY MARKERVALUES IN PREDICTING RESIDUAL TIME TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME DIAGNOSIS
Authors: SHI MG TAYLOR JMG CURRIER RJ TANG H HOOVER DR CHMIEL JS BRYANT JL SAAH A MUNOZ A MARGOLICK J PHAIR J DETELS R GIORGI JV RINALDO C
Citation: Mg. Shi et al., REPLACING TIME SINCE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION BY MARKERVALUES IN PREDICTING RESIDUAL TIME TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME DIAGNOSIS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(3), 1996, pp. 309-316
SEROCONVERSION TO ANTIBODIES AGAINST KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-RELATED LATENT NUCLEAR ANTIGENS BEFORE THE DEVELOPMENT OF KAPOSIS-SARCOMA
Authors: GAO SJ KINGSLEY L HOOVER DR SPIRA TJ RINALDO CR SAAH A PHAIR J DETELS R PARRY P CHANG Y MOORE PS
Citation: Sj. Gao et al., SEROCONVERSION TO ANTIBODIES AGAINST KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-RELATED LATENT NUCLEAR ANTIGENS BEFORE THE DEVELOPMENT OF KAPOSIS-SARCOMA, The New England journal of medicine, 335(4), 1996, pp. 233-241
MOLECULAR-CLONING AND ANALYSIS OF FUNCTIONAL ENVELOPE GENES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEQUENCE SUBTYPE-A THROUGH SUBTYPE-G
Authors: GAO F MORRISON SG ROBERTSON DL THORNTON CL CRAIG S KARLSSON G SODROSKI J MORGADO M GALVAOCASTRO B VONBRIESEN H BEDDOWS S WEBER J SHARP PM SHAW GM HAHN BH OSMANOV S HEYWARD WL ESPARZA J VANDEPERRE P KARITA E SEMPALA S TUGUME B BIRYAHWAHO B WASI C RUBSAMENWAIGMANN H HOLMES H NEWBERRY A RANJBAR S TOMLINSON P BRADAC J MULLINS JI DELWART EL CHEINGSONGPOPOV R KALEEBU P MYERS G KORBER BTM CHIPHANGWI J TAHA T DESORMEAUX J EIUMTRAKUL S NATPRATAN C KHAMBOONRUANG C MIOTTI P HALSEY NA VLAHOV D NELSON KE PHAIR J CAO Y MOORE JP HO DD MATOCHA M FOWLER A DILWORTH S SHARMA O BROWN R DUSING S WHITMAN J HOEKZEMA D VOGEL F
Citation: F. Gao et al., MOLECULAR-CLONING AND ANALYSIS OF FUNCTIONAL ENVELOPE GENES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEQUENCE SUBTYPE-A THROUGH SUBTYPE-G, Journal of virology, 70(3), 1996, pp. 1651-1667
HIV-1 GP120-SPECIFIC ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY CORRELATES WITH RATE OF DISEASE PROGRESSION
Authors: BAUM LL CASSUTT KJ KNIGGE K KHATTRI R MARGOLICK J RINALDO C KLEEBERGER CA NISHANIAN P HENRARD DR PHAIR J
Citation: Ll. Baum et al., HIV-1 GP120-SPECIFIC ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY CORRELATES WITH RATE OF DISEASE PROGRESSION, The Journal of immunology, 157(5), 1996, pp. 2168-2173
ASSESSMENT OF CYTOMEGALOVIRUS RETINITIS - CLINICAL-EVALUATION VS CENTRALIZED GRADING OF FUNDUS PHOTOGRAPHS
Authors: LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO TC TUTTLE C JABS DA APUZZO L BARTLETT J COLESON L DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D HEINEMANN MD POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG TW JUSTIN N TEICH S SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MCARTHURCHANG L FREEMAN WR MEINERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R CHEESMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K KLINE JM KLEMM AC STEVENS M WEBB R BROWNBELLAMY J MARKOWITZ JA BROOKMEYER R COLLINS KB COLLISON BJ DODGE J DONITHAN M FINK N GILPIN AMK GERCZAK C HOLBROOK JT ISAACSON MR LEVINE CR MARTIN B MIN YI OWENS RM NOWAKOWSKI DJ SAAH A SINGER S SMITH M STERNBERG AL TONASCIA J VANNATTA ML DAVIES MD AGRESSEGAL M ARMSTRONG J BRICKBAUER J BROTHERS R FREITAG G HUBBARD L HURLBURT D JENSEN K KASTORFF L KING B MAGLI Y MESSING S MINER K NEIDER M ONOFREY J STOPPENBACH V THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R WELCH L KURINIJ N MOWERY R ELLENBERG S KORVICK J DAVIS MD CLARK T CLOGSTON PS FREEMAN W KOLVICK J MOWERY R SATTLER F BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H WHITLEY R BOWERS M CHENG B LAMBERT AG LINK D
Citation: Ra. Lewis et al., ASSESSMENT OF CYTOMEGALOVIRUS RETINITIS - CLINICAL-EVALUATION VS CENTRALIZED GRADING OF FUNDUS PHOTOGRAPHS, Archives of ophthalmology, 114(7), 1996, pp. 791-805
MEASURING VISUAL FUNCTION AND QUALITY-OF-LIFE IN PATIENTS WITH CYTOMEGALOVIRUS RETINITIS - DEVELOPMENT OF A QUESTIONNAIRE
Authors: WU AW COLESON LC HOLBROOK J JABS DA LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO T TUTTLE C APUZZO L BARTLETT J DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN MH POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG AW JUSTIN N TEICH S SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MACARTHUR LJ FREEMAN WR MEIXNERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R CHEESEMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K KLINE JM KLEMM AC STEVENS M WEBB R BROWNBELLAMY J MARKOWITZ JA MEINERT CL BINDER KL BROOKMEYER R BROWN VE COLLISON BJ DODGE J DONITHAN M FINK N GERCZAK C HOLBROOK JT ISAACSON MR JONES CP LEVINE CR MIN YI MEINERT JL OWENS RM NOWAKOWSKI DJ SAAH A SANDFORD GR SINGER S SMITH M STERNBERG AL TONASCIA J VANNATTA ML DAVIS MD AGRESSEGAL M ARMSTRONG J BROTHERS R FREITAG G HUBBARD L HURLBURT D KASTORFF L MAGLI Y MINER K THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R WELCH L MOWERY R ELLENBERG S KORVICK J CLARK T CLOGSTON PS FREEMAN W HARDY D SATTLER F JORDAN C MILLS J BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H
Citation: Aw. Wu et al., MEASURING VISUAL FUNCTION AND QUALITY-OF-LIFE IN PATIENTS WITH CYTOMEGALOVIRUS RETINITIS - DEVELOPMENT OF A QUESTIONNAIRE, Archives of ophthalmology, 114(7), 1996, pp. 841-847
CLINICAL VS PHOTOGRAPHIC ASSESSMENT OF TREATMENT OF CYTOMEGALOVIRUS RETINITIS - FOSCARNET-GANCICLOVIR CYTOMEGALOVIRUS RETINITIS TRIAL REPORT-8
Authors: LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO TC TUTTLE C JABS DA APUZZO L BARTLETT J COLESON L DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN MH POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG TW JUSTIN N TEICH S SACKS H SEVERIN C ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MACARTHURCHANG L FREEMAN WR MEINERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R CHEESMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K KLINE JM KLEMM AC STEVENS M WEBB R BROWNBELLAMY J MARKOWTIZ JA MEINERT CL BROOKMEYER R COLLINS KB COLLISON BJ DODGE J DONITHAN M FINK N GILPIN AMK GERCZAK C HOLBROOK JT ISAACSON MR LEVINE CR MARTIN B MIN YI MEINERT JL OWENS RM NOWAKOWSKI DJ SAAH A SINGER S SMITH M STERNBERG AL TONASCIA J VANNATTA ML DAVIS MD AGRESSEGAL M ARMSTRONG J BRICKBAUER J BROTHERS R FREITAG G HUBBARD L HURLBURT D JENSEN K KASTORFF L KING B MAGLI Y MESSING S MINER K NEIDER M ONOFREY J STOPPENBACH V THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R WELCH L KURINIJ N MOWERY R ELLENBERG S KORVICK J CLARK T CLOGSTON PS FREEMAN W HOLBROOK JT KOLVICK J MARKOWITZ JA SATTLER F CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H WHITLEY R CHENG B LAMBERT AG LINK D
Citation: Ra. Lewis et al., CLINICAL VS PHOTOGRAPHIC ASSESSMENT OF TREATMENT OF CYTOMEGALOVIRUS RETINITIS - FOSCARNET-GANCICLOVIR CYTOMEGALOVIRUS RETINITIS TRIAL REPORT-8, Archives of ophthalmology, 114(7), 1996, pp. 848-855
USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - INTRODUCTION/
Authors: KAPLAN JE MASUR H HOLMES KK MCNEIL MM SCHONBERGER LB NAVIN TR HANSON DL GROSS PA JAFFE HW LANIER D SCHRAM N COOPER E FREEDBERG KA MAYER K BLINKHORN R ELLNER J ANGULO F BERKELMAN R BREIMAN R BRYAN R BUEHLER J CLADWELL B CASTRO K CHILDS JE CHU S CIESIELSKI C DROTMAN DP EDLIN B ELLERBROCK T FLEMING P GEITER L HAJJEH R HANSON D HOLMBERG S HUGHES J JAFFE H JONES J JURANEK D KAPLAN JE KELLER D MARTONE W MILLER B NAVIN T NESLUND V OSTROFF S PELLETT PE PINNER R REEF S REEVES WC REGNERY R RICHARDS F ROGERS M SIMONDS RJ SIMONE P SMITH D SOLOMON S SPIEGEL R STEWART J SWERDLOW D VERNON S WARD J NEAL J SCHLECH W WILFERT C HORSBURGH R MCGOWAN J RIMLAND D GOLDBERGER M TRAPNELL CB BARR D TORRES G STETLER H GROSS P ELSADAR W COTTON D GREAVES W BARTLETT J CHAISSON R FEINBERG J QUINN T HORMAN J MACDONALD K WILSON M SPERLING R AVANDANO A BAKER AC KALICA A KOVACS J POLIS M SCHNITTMAN S NELSON C PHAIR J BENSON C WOOD B HUGHES W LUFT B HYSLOP N WHITLEY R AMPEL N DREW WL KOEHLER J WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - INTRODUCTION/, Clinical infectious diseases, 21, 1995, pp. 1-11
USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - AN OVERVIEW/
Authors: KAPLAN JE MASUR H HOLMES KK WILFERT CM SPERLING R BAKER SA TRAPNELL CB FREEDBERG KA COTTON D POWDERLY WG JAFFE HW LANIER D SCHRAM N COOPER E MAYER K BLINKHORN R ELLNER J ANGULO J BERKELMAN R BREIMAN R BRYAN R BEUHLER J CALDWELL B CASTRO K CHILDS JE CHU S CIESIELSKI C DROTMAN DP EDLIN B ELLERBROCK T FLEMING P GEITER L HAJJEH R HANSON D HOLMBERG S HUGHES J JAFFE H JONES J JURANEK D KELLER D MARTONE W MCNEIL MM MILLER B NAVIN T NESLUND V OSTROFF S PELLETT PE PINNER R REEF S REEVES WC REGNERY R RICHARDS F ROGERS M SCHONBERGER LB SIMONDS RJ SIMONE P SMITH D SOLOMON S SPIEGEL R STEWART J SWERDLOW D VERNON S WARD J NEAL J SCHLECH W WILFERT C HORSBURGH R MCGOWAN J RIMLAND D GOLDBERGER M BARR D TORRES G STETLER H GROSS P ELSADR W GREAVES W BARTLETT J CHAISON R FEINBERG J QUINN T HORMAN J MACDONALD K WILSON M AVANDANO A BAKER AC KALICA A KOVACS J POLIS M SCHNITTMAN S NELSON C PHAIR J BENSON C WOOD B HUGHES W LUFT B HYSLOP N WHITLEY R AMPEL N DREW WL KOEHLER J WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - AN OVERVIEW/, Clinical infectious diseases, 21, 1995, pp. 12-31
USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/
Authors: KAPLAN JE MASUR H HOLMES KK LANIER D SCHRAM N COOPER E FREEDBERG KA MAYER K BLINKHORN R ELLNER J ANGULO F BERKELMAN R BREIMAN R BRYAN R BUEHLER J CALDWELL B CASTRO K CHILDS JE CHU S CIESIELSKI C DROTMAN DP EDLIN B ELLERBROCK T FLEMING P GEITER L HAJJEH R HANSON D HOLMBERG S HUGHES J JAFFE H JONES J JURANEK D KELLER D MARTONE W MCNEIL MM MILLER B NAVIN T NESLUND V OSTROFF S PELLETT PE PINNER R REEF S REEVES WC REGNERY R RICHARDS F ROGERS M SCHONBERGER LB SIMONDS RJ SIMONE P SMITH D SOLOMON S SPIEGEL R STEWART J SWERDLOW D VERNON S WARD J NEAL J SCHLECH W WILFERT C HORSBURGH R MCGOWAN J RIMLAND D GOLDBERGER M TRAPNELL CB BARR D TORRES G STETLER H GROSS P ELSADR W COTTON D GREAVES W BARTLETT J CHAISSON R FEINBERG J QUINN T HORMAN J MACDONALD K WILSON M SPERLING R AVANDANO A BAKER AC KALICA A KOVACS J POLIS M SCHNITTMAN S NELSON C PHAIR J BENSON C WOOD B HUGHES W LUFT B HYSLOP N WHITLEY R AMPEL N DREW WL KOEHLER J WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/, Clinical infectious diseases, 21, 1995, pp. 32-43
HLA CLASS-I, CLASS-II, AND TAP GENES STRONGLY INFLUENCE THE COURSE OFHIV-INFECTION
Authors: MANN DL KASLOW RA APPLE R CARRINGTON M MUNOZ A PARK L DETELS R RINALDO C PHAIR J GEODERT J SAAH A
Citation: Dl. Mann et al., HLA CLASS-I, CLASS-II, AND TAP GENES STRONGLY INFLUENCE THE COURSE OFHIV-INFECTION, Journal of cellular biochemistry, 1995, pp. 34-34
LONG-TERM SURVIVAL WITHOUT CLINICAL AIDS AFTER CD4+ CELL COUNTS FALL BELOW 200X10(6) I/
Authors: HOOVER DR RINALDO C HE YH PHAIR J FAHEY J GRAHAM NMH
Citation: Dr. Hoover et al., LONG-TERM SURVIVAL WITHOUT CLINICAL AIDS AFTER CD4+ CELL COUNTS FALL BELOW 200X10(6) I/, AIDS, 9(2), 1995, pp. 145-152
Risultati: 1-25 | 26-35